About 4D Molecular Therapeutics, Inc. Common Stock
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Market Cap
$0.17B
Employees
227
Listed Since
December 11, 2020
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Phone
(510) 505-2680
Headquarters
5858 HORTON STREET #455
EMERYVILLE, CA 94608
CIK
0001650648